cAMP responsive element binding protein 3 (CREB3) hinders the progression of hepatocellular carcinoma (HCC) by suppressing the phosphorylation of AKT signaling through binding competitively with insulin receptor substrate 1 (IRS1) to insulin receptor (INSR). This evidence concerns the gene AKT1 and hepatocellular carcinoma.